First drug approval in NASH
When we reviewed the R&D landscape in nonalcoholic steatohepatitis (NASH) in 2018, we highlighted 4 development programs that were in Phase 3 development and all targeting pivotal data readout, and a potential launch, between 2019 and 2021. However, obeticholic acid, elafibranor, cenicriviroc, and selonsertib all turned out to not confirm their initial positive data in […]
SMR meeting: The Innovation Landscape
On Tuesday 26 March Darcey Black, Translational Science Director at TherapeutAix, will be co-organising and co-sharing the SMR meeting taking place at Friends House, London. This SMR meeting follows on from the 2022 conference on ‘Innovative new pharma and biotech partnerships: How is the landscape transforming?’ and its goal is to better understand these evolutionary […]
Welcome 2024
With the New Year up and running, we all got together in Aachen for a Board Meeting. In addition to mapping out activities for 2024, we focused on two additional areas. The first was a strategic review of our services and how these align with our client’s needs. While we’re receiving superb feedback in our […]
TherapeutAix Roundup: 2023
As 2023 comes to an end we wanted to take the time to reflect upon the year and share what we have been up to. From supporting our clients, participating in scientific meetings, and facilitating workshops to refreshing our website, it has been a busy year for the team at TherapeutAix. Our clients and their […]
SMR: Recent Clinical Candidates and SMR Award Meeting
Darcey Black, Translational Science Director at TherapeutAix, will be attending the bi-annual SMR Meeting taking place at Friends House, London, on Monday 4th December. The meeting will include presentations highlighting recent clinical candidates across therapeutic areas including cancer, immune disease and more, with a variety of targeting modalities. The meeting will include the presentation of […]
TherapeutAix to attend ERS International Congress
TherapeutAix will be at the ERS International Congress 2023 taking place in Milan, Italy from 9-13 September. The Congress, hosted at MiCo, will bring together the world’s respiratory experts to showcase the latest advances in respiratory medicine and science. The theme of this year’s Congress is ‘Pollution, climate change and sustainable developments’ and will look at the […]
Join TherapeutAix at the SMR Meeting ‘Innovative New Pharma & Biotech Partnerships’
Darcey Black, Translational Director at TherapeutAix, will be co-organising and attending the ‘Innovative New Pharma and Biotech Partnerships: How is the landscape transforming?’ SMR Meeting taking place on 7th July 2022 at GSK Stevenage. The meeting will feature a panel; of experts from industry, CROs, medical charities and VCs who will share experiences and lessons […]
International NASH Day 2022 – Enabling therapies for patients
Non-alcoholic steatohepatitis, or NASH, remains a disease with no approved therapeutics. And it’s been a tough area for drug development, with numerous Phase 2b and Phase 3 failures in the last few years. As a result, the landscape of active development projects has changed quite a bit from the time our review on NASH was […]
TherapeutAix to present at Extracellular Matrix Pharmacology Congress
TherapeutAix is attending and presenting at the Extracellular Matrix Pharmacology Congress 2022, on 23-25 June at the Tivoli Congress Centre in Copenhagen. The congress will bring together experts from across the industry to discuss the extracellular matrix across organ diseases including liver, lung, kidney, skin, and immunology. Darcey Black (Director, Translational) will be presenting a […]
TherapeutAix to host Outsourcing Workshop at BOS Virtual 2021
Darcey Black and Simon Cruwys will be running the Outsourcing Workshop at this year’s BOS Virtual. Biotech Outsourcing Strategies is an established outsourcing focused conference and exhibition for the international Pharmaceutical industry. The event scope is focused on Discovery outsourcing and CMC outsourcing for both small molecules and biologics (primarily development stage). Darcey will be introducing the session and will explain the TherapeutAix model for collaboration […]